I-Mab Appoints Ruyi He and Rong Shao to Board of Directors
Dr. Ruyi He will serve on the compensation committee and Professor Shao will serve on the corporate governance committee both effective June 1,2021.
- Dr. Ruyi He will serve on the compensation committee and Professor Shao will serve on the corporate governance committee both effective June 1,2021.
- He and Professor Shao to our board, and look forward to their wealth of industry experience and breadth of relationships as we transform into a fully integrated global biopharmaceutical company.
- He joined the NMPA in 2016, after having worked at the U.S. Food and Drug Administration (FDA) for almost two decades.
- I am delighted to share my knowledge and experience to support in the next phase of this meaningful evolution," said Professor Rong Shao.